Use of insulin detemir was associated with a significant reduction in the risk of nocturnal hypoglycaemia in the majority of studies (31–37) [up to 87% or 90% risk reduction compared with NPH insulin (35,38)]. The gene discussed is INS; the disease is Hypoglycemia.